126 related articles for article (PubMed ID: 3054035)
1. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
Salam MA; Bennish ML
J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
Haltalin KC; Nelson JD; Kusmiesz HT
Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
[TBL] [Abstract][Full Text] [Related]
5. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.
Bennish ML; Salam MA; Haider R; Barza M
J Infect Dis; 1990 Sep; 162(3):711-6. PubMed ID: 2201742
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
7. Response to antimicrobial therapy for shigellosis in Thailand.
Lolekha S; Vibulbandhitkit S; Poonyarit P
Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
9. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
Hansson HB; Barkenius G; Cronberg S; Juhlin I
Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
Datta P; Sen D
Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children.
Varsano I; Eidlitz-Marcus T; Nussinovitch M; Elian I
J Pediatr; 1991 Apr; 118(4 Pt 1):627-32. PubMed ID: 2007941
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.
Kabir I; Rahaman MM; Ahmed SM; Akhter SQ; Butler T
Antimicrob Agents Chemother; 1984 May; 25(5):643-5. PubMed ID: 6329092
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefaclor and ampicillin in the treatment of shigellosis.
Ostrower VG
Postgrad Med J; 1979; 55 Suppl 4():82-4. PubMed ID: 398485
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children.
Helvaci M; Bektaşlar D; Ozkaya B; Yaprak I; Umurtak B; Ertuğrul A
Acta Paediatr Jpn; 1998 Apr; 40(2):131-4. PubMed ID: 9581302
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid.
Bennish ML; Salam MA; Hossain MA; Myaux J; Khan EH; Chakraborty J; Henry F; Ronsmans C
Clin Infect Dis; 1992 May; 14(5):1055-60. PubMed ID: 1600006
[TBL] [Abstract][Full Text] [Related]
17. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
[TBL] [Abstract][Full Text] [Related]
20. Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it.
Islam MR; Alam AN; Hussain MS; Mahalanabis D
J Trop Med Hyg; 1995 Apr; 98(2):121-5. PubMed ID: 7714935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]